What researchers published on Mezotelióma
6203 papers, newest first.
Showing 20 of 6203
RETRACTED: Ramundo et al. APE-1/Ref-1 Inhibition Blocks Malignant Pleural Mesothelioma Cell Proliferation and Migration: Crosstalk Between Oxidative Stress and Epithelial Mesenchymal Transition (EMT) in Driving Carcinogenesis and Metastasis. Int. J. Mol. Sci. 2023, 24, 12570.International journal of molecular sciences
Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma.Cureus
The Sibaté Asbestos-Cement Facility Case Study: Reconstructing the Production Process to Assess Occupational and Environmental Impacts.Annals of global health
ÁttekintésReview of Registries, Databases and Biobanks for Surveillance and Research on Mesothelioma.Cancers
ÁttekintésBeyond Mesothelioma: From Diagnostic Biomarker to Therapeutic Opportunity-The Emerging Role of MTAP in Cancer.International journal of molecular sciences
Real-World Outcomes of Oral VEGFR Tyrosine Kinase Inhibitor-Containing Therapy in Unresectable Malignant Mesothelioma: A Single-Center Retrospective Study.Cancers
Correction: Machine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study.Frontiers in genetics
Recent advances in the treatment of pleural mesothelioma.Current opinion in oncology
Targeting the CCL5-CCR5 axis protects against chemoresistant mesothelioma development through macrophage reprogramming.Cancer letters
High-Pressure/High-Dose Versus Standard PIPAC in Epithelioid Peritoneal Mesothelioma: Safety, Feasibility, and Outcomes From a Bicentric Comparative Cohort Study.Annals of surgical oncology
Evolution and distribution of malignant pleural mesothelioma mortality in Spain: 2016-2022.Pulmonology
Outcomes of Platinum plus /Pemetrexed Rechallenge in Pleural Mesothelioma: The Role of Platinum-Free Interval in a Multicenter Real-World Analysis.JTO clinical and research reports
Multiomics Analysis of Malignant Pleural Mesothelioma Reveals the Immunological Microenvironment Associated with MTAP Loss and Immunotherapy Outcomes.Clinical cancer research : an official journal of the American Association for Cancer Research
[Current State of the Asbestos Outpatient Clinic and an Evaluation of Asbestos Bodies].Kyobu geka. The Japanese journal of thoracic surgery
Esetismertetés[Surgical Case of Primary Malignant Pericardial Mesothelioma].Kyobu geka. The Japanese journal of thoracic surgery
USP14 promotes malignant pleural mesothelioma progression and suppresses autophagy by stabilizing the YAP1-TEAD4 axis.Molecular biology reports
ÁttekintésCross-lineage mesenchymal transition in mesothelioma.Cancer metastasis reviews
Prognostic factors after multimodality treatment for pleural mesothelioma.Interdisciplinary cardiovascular and thoracic surgery
Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.Frontiers in oncology
Multimodality imaging in the diagnosis and staging of malignant pleural mesothelioma.BMJ case reports